This test is most useful if any of these apply to you.
Chronic liver disease can develop without symptoms, and an abnormal blood test may be the first clue. This panel combines signs of liver cell injury, problems with bile flow, and changes in blood proteins. Reading those signals together helps distinguish a possible liver or bile-duct problem from changes caused by muscle injury, inflammation elsewhere, or an inherited difference in bilirubin processing.
These are established clinical tests, but an abnormal pattern usually narrows the possibilities without identifying the cause by itself. Your symptoms, medications, alcohol use, metabolic health, and earlier results determine what the pattern means.
ALT and AST are enzymes that can rise when liver cells are injured. Their full names are alanine aminotransferase and aspartate aminotransferase. ALT is more concentrated in the liver, while AST also comes from muscle and other tissues. The size of an increase helps guide the search for a cause, but it doesn't reliably measure how much functioning liver remains.
ALP measures alkaline phosphatase activity. It often rises when bile flow is impaired, though bone can also be the source. Bile carries waste from the liver into the intestine. Bilirubin is a yellow waste pigment produced mainly when red blood cells break down. Comparing the injury enzymes with the bile-related results helps distinguish cell injury from impaired drainage, while allowing for conditions that cause both.
Albumin is a blood protein made by your liver. A low result can reflect reduced production in advanced liver disease, but inflammation, fluid balance, and protein loss through the kidneys or gut also affect it. The remaining blood proteins include antibodies and transport proteins, so their combined level adds information about immune activity and protein balance. A high level can come from liver disease, but also from chronic infection, autoimmune disease, or a disorder of antibody-producing blood cells such as multiple myeloma. In people with biopsy-confirmed fatty liver disease, lower albumin was associated with a higher risk of death or liver transplantation. That association doesn't establish the cause of a low result in someone without a diagnosis.
Compare enzyme results as multiples of each test's upper reference limit. Raw numbers from different enzyme tests aren't directly comparable. For bilirubin, the direct fraction mainly reflects pigment your liver has processed for removal in bile. The indirect fraction estimates pigment before that processing step.
| Pattern | Interpretation |
|---|---|
| ALT and AST elevated more than ALP, relative to their respective limits | A liver cell injury pattern. Possible causes include metabolic fatty liver, alcohol, viral hepatitis, immune disease, and medications or supplements. Muscle injury can also raise these enzymes. |
| ALP elevated more than ALT and AST, especially with elevated direct bilirubin | An impaired bile-flow pattern. Causes include blocked or inflamed bile ducts and some drug reactions. Additional testing helps confirm whether the ALP comes from liver. |
| Mildly elevated indirect bilirubin with otherwise normal liver results | Compatible with Gilbert syndrome once increased red-cell breakdown and medication effects have been excluded. Gilbert syndrome is an inherited reduction in bilirubin processing that usually needs no treatment. |
| Low albumin with high total globulin | Can occur with chronic liver disease, but also with chronic infection, autoimmune disease, or antibody-producing blood cell disorders such as multiple myeloma. It doesn't identify the cause or prove advanced scarring. |
| Normal total protein with low albumin and high total globulin | Opposing changes can leave the total within range. The separate results reveal a protein imbalance that the total alone would conceal. |
Bile-duct disease can raise the injury enzymes too, and bilirubin can remain normal early on. AST above ALT can occur with alcohol-associated disease, advanced scarring, or muscle injury, but the relationship alone cannot diagnose any of them. Low albumin also needs attention when the enzymes are normal; advanced liver disease remains possible alongside non-liver causes.
An unflagged ALT isn't always reassuring. Some laboratories use an upper limit of 40 units per liter or higher. A pooled analysis estimated healthy upper limits of 36 in men and 28 in women using the same units. Persistent levels above these estimates deserve assessment, especially with metabolic risk factors, even if your report doesn't flag them. The American College of Gastroenterology also recommends assessment at lower levels than many laboratory cutoffs.
Studies of healthy populations produce different limits depending on who is included and how the limit is calculated. They estimate reference ranges; trials haven't established an ALT target that lengthens life. A falling enzyme level can accompany recovery, but it should be interpreted with bilirubin, protein results, symptoms, and the underlying diagnosis.
Fibrosis is scar tissue that accumulates in the liver. Advanced scarring can be present despite normal injury enzymes, so normal results don't exclude serious chronic liver disease.
The fibrosis-4 score estimates the likelihood of advanced scarring from your age, ALT, AST, and platelet count. It is usually labeled FIB-4. Platelets are measured separately from this panel. This assessment is useful if you have type 2 diabetes, obesity with additional metabolic risk factors, or suspected fatty liver. A low score reduces the likelihood of advanced scarring; an intermediate or high result can lead to a liver stiffness scan or the Enhanced Liver Fibrosis blood test. Neither follow-up test guarantees a definitive answer. Age affects the score's accuracy and interpretation, and it shouldn't be used during acute illness.
Recent strenuous exercise, acute illness, changes in hydration, alcohol, and medicines can alter the pattern. Some changes come from outside the liver. Collection and processing problems can also affect results, including damage to blood cells in the sample. Interpret a change alongside those circumstances and earlier measurements, preferably from the same laboratory.
A liver cell injury pattern commonly leads to hepatitis testing, iron studies, and a review of alcohol, medicines, and supplements. Imaging and tests for immune-related liver disease depend on the findings. A bile-flow pattern usually leads to confirmation of a liver source and an abdominal ultrasound. An isolated indirect bilirubin rise calls for checking red-cell breakdown before concluding that you have Gilbert syndrome.
If you feel well and a result is mildly abnormal, repeat the panel first. In a large US sample retested a few weeks apart, more than 30% of elevated injury-enzyme or bilirubin results had returned to normal. For an isolated alkaline phosphatase rise, adding gamma-glutamyl transferase can confirm whether the liver is the source. A result that persists on repeat deserves a cause-focused assessment even when the rise is mild. Symptoms, markedly high enzymes, rising bilirubin, signs of reduced liver function, or concerning scarring assessments warrant prompt specialist evaluation rather than waiting for a repeat.
Hepatic Function Panel is best interpreted alongside these tests.
Your full-body baseline that catches heart, blood sugar, and organ trouble years before it would ever make you feel sick.
72 biomarkers